Autoantigen Recognition by Human CD8 T Cell Clones: Enhanced Agonist Response Induced by Altered Peptide Ligands

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4943-4951

  Dressel, Alexander ^a   Chin, Jonathan L ^a   Sette, Alessandro ^b   Gausling, Rudolf ^a   Höllsberg, Per ^a   Hafler, David A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CYTEL CORPORATION   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; INTERLEUKIN 4; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN BASIC PROTEIN; PEPTIDE; PROTEOLIPID;

AMINO ACID SUBSTITUTION; ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL LINE; CYTOTOXICITY; DRUG POTENTIATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS; SECRETION;

AMINO ACID SUBSTITUTION; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LIGANDS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDES; PROTEOLIPIDS; RECEPTORS, ANTIGEN, T-CELL;

EID: 0031573209     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
2. Martin, R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker, E. Long, D. McFarlin, and H. McFarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540.
3. Martin, R., M. D. Howell, D. Jaraquemada, M. Flerlage, J. Richert, S. Brostoff, E. O. Long, D. E. McFarlin, and H. F. McFarland. 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:19.
4. Pette, M., K. Fujita, D. Wilkinson, D. M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J. T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87:7968.
5. Meinl, E., F. Weber, K. Drexler, C. Morelle, M. Ott, G. Saruhan-Direskeneli, N. Goebeis, B. Ertl, G. Jechart, G. Giegerich, S. Schonbeck, W. Bannwarth, H. Wekerle, and R. Hohlfeld. 1993. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. J. Clin. Invest. 92:2633.
6. Wucherpfennig, K., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. Strominger, and D. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
7. Ausubel, L., C. Kwan, A. Sette, V. Kuchroo, and D. Hafler. 1996. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc. Natl. Acad. Sci. USA 93:15317.
8. Wucherpfennig, K., and J. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
9. Vergelli, M., B. Hemmer, U. Utz, A. Vogt, M. Kalbus, L. Tranquill, P. Conlon, N. Ling, L. Steinman, H. McFarland, and R. Martin. 1996. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26:2624.
10. + cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J. Neuroimmunol. 73:7.
11. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91:10859.
12. Hauser, S., A. Bhan, F. Gilles, M. Kemp, C. Kerr, and H. Weiner. 1986. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19:578.
13. Grenier, Y., T. Ruijis, Y. Robitaille, A. Olivier, and J. Antel. 1989. Immunohitochemical studies of adult human glial cells. J. Neuroimmunol. 21:103.
14. + T-cell population: analysis using a multiplex PCR assay for CDR3 length. Ann. NY Acad. Sci. 756:19.
15. + T-cells in multiple sclerosis. Ann. NY Acad. Sci. 756:310.
16. Jurewicz, A., W. Biddison, and J. Antel. 1997. MHC class I-restricted killing of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. Neurology 48:A381.
17. Kersh, G., and P. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature 380:495.
18. Bertoletti, A., A. Sette, F. Chisarl, A. Penna, M. Levrero, M. DeCarli, F. Flaccadori, and C. Ferrarl. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407.
19. Klenerman, P., S. Rowland-Jones, S. Mcdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. Phillips, and A. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
20. Höllsberg, P., W. Weber, F. Dangond, V. Batra, A. Sette, and D. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 92:4036.
21. + T-cell clones. FASEB J. 10:A1314.
22. Bieganowska, K. D., L. J. Ausubel, Y. Modabber, E. Slovik, W. Messersmith, and D. A. Hafler. 1997. Direct ex vivo analysis of activated, FAS-sensitive autoreactive T cells in human autoimmune disease. J. Exp. Med. 185:1.
23. Ben Nun, A., R. S. Liblau, L. Cohen, D. Lehmann, E. Tournier Lasserve, A. Rosenzweig, J. W. Zhang, J. C. Raus, and M. A. Bach. 1991. Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA 88:2466.
24. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
25. Zhou, L. J., R. Schwarting, H. Smith, and T. Tedder. 1992. A novel cell-surface molecule expressed by human reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149:735.
26. Ruppert, J., J. Sidney, E. Celis, R. Kubo, H. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
27. Hunt, D., H. Michel, T. Dickinson, J. Shabanowitz, A. Cox, K. Sakaguchi, E. Appella, H. Grey, and A. Sette. 1992. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256:1817.
28. Parker, K., M. Bednarek, L. Hull, U. Utz, B. Cunningham, H. Zweerink, W. Biddison, and J. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149:3580.
29. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
30. Gulukotat, K., J. Sidney, A. Sette, and C. DeLisi. 1997. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol. 268:1.
31. Sette, A., S. Buus, S. Colon, C. Miles, and H. Grey. 1989. Structural analysis of peptides capable of binding to more than one Ia antigen. J. Immunol. 142:35.
32. Rebai, N., and B. Malissen. 1983. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22:107.
33. Barnstable, C., W. Bodmer, G. Brown, G. Galfre, C. Milstein, A. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.
34. Buus, S., A. Sette, S. Colon, C. Miles, and H. Grey. 1987. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353.
35. Höllsberg, P., V. Batra, A. Dressel, and D. Hafler. 1996. Induction of anergy in CD8 T cells by B cell presentation of antigen. J. Immunol. 157:5269.
36. Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. Fritsch, R. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
37. Fukaura, H., S. Kent, M. Pietrusewicz, S. Khoury, H. Weiner, and D. Hafler. 1996. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:70.
38. Höllsberg, P., K. W. Wucherpfennig, L. J. Ausubel, V. Calvo, B. E. Bierer, and D. A. Hafler. 1992. Characterization of HTLV-I in vivo-infected T cell clones: IL-2-independent growth of non transformed T cells. J. Immunol. 148:3256.
39. (27-35). J. Exp. Med. 184:647.
40. Solinger, A., M. Ultee, E. Margoliash, and R. Schwartz. 1979. T-lymphocyte response to cytochrome c: demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes. J. Exp. Med. 150: 830.
41. + T cells in the thymus. Cell 73:1041.
42. Spain, L. M., J. L. Jorgensen, M. M. Davis, and L. J. Berg. 1994. A peptide antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J. Immunol. 152:1709.
43. Traugott, U. 1990. Evidence for immunopathogenesis. In Handbook of Multiple Sclerosis. S. Cook, ed. Marcel Dekker, Inc., London, p. 101.
44. Allegretta, M., J. A. Nicklas, S. Sriram, and R. J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718.
45. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. Weiner, and D. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973.